Johns Hopkins cancer treatment spinout launches with $150M, establishes D.C.-area hub
The company plans to expand in the region. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Remarkable Patients Inspired Father of Cancer Immunotherapy Remarkable Patients Inspired Father of Cancer Immunotherapy
The father of cancer immunotherapy, Steven A. Rosenberg, reflects on the patients who inspired his groundbreaking research.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Johns Hopkins cancer treatment spinout launches with $150M in funding
Hopkins professor Bert Vogelstein has started several companies in Baltimore focused on cancer diagnostics that have sold for hundreds of millions of dollars. Now he is venturing into cancer treatment with Clasp Therapeutics. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2024 Category: Pharmaceuticals Authors: Matt Hooke Source Type: news

Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
Geron Inc. NASDAQ: GERN is a clinical-stage biotech in the medical sector focused on developing cell therapies to treat certain types of blood cancers and myeloid hematologic malignancies. Their lead drug is imetelstat, which blocks a protein called telomerase to treat specific blood cancers like…#geroninc #gern #myeloid #fda #genetherapygene #crisprtherapeuticsag #crsp #scd #imetelstat #mds (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news

5 Signs You Should Get A Colonoscopy Before You Turn 45
Rates of colorectal cancer are rising among young people. Don't ignore these red flags. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 20, 2024 Category: Consumer Health News Source Type: news

Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help identify patients who may benefit from Bayer's growing portfolio of precision cancer therapies by offering decentralized genomic testing and rapid turnaround time. (Source: World Pharma News)
Source: World Pharma News - March 20, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

ARPA-H taps Pisano for'Advancing Clinical Trials Readiness' initiative
The Advanced Research Projects Agency for Health (ARPA-H) has tapped the American College of Radiology's (ACR) Chief Research Officer Etta Pisano, MD, to develop its clinical trial portfolio and lead its Advancing Clinical Trials Readiness initiative. The ARPA-H is a new federal health research and development organization within the U.S. Department of Health and Human Services. Pisano is the first radiologist appointed to such a role in the ARPA-H, and she will lead the initiative under the agency's Resilient Systems Mission office director, Jennifer Roberts, PhD, according to a statement released by the ACR. In the posi...
Source: AuntMinnie.com Headlines - March 20, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Practice Management Source Type: news

iCAD updates AI software for detecting breast cancer
Computer-aided detection (CAD) software developer iCAD has launched new features for its ProFound Detection AI software tool designed to help radiologists diagnose cancer on both 2D and 3D mammography. The latest version of ProFound Detection includes a new configuration option limiting to three the number of lesion marks visible on a workstation view displaying 3D images. This refinement is hoped to ensure that radiologists can interpret the most critical information, the company said. As a visual aid, iCAD has also introduced color-coded lesion marks and case scores on the ProFound Scorecard. The color-coded system is ...
Source: AuntMinnie.com Headlines - March 20, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin
(MedPage Today) -- A common chemotherapy drug used to treat Hodgkin lymphoma conferred a significantly increased risk of breast cancer among women treated during adolescence and adulthood, a large retrospective study showed. Women who received... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2024 Category: Hematology Source Type: news

Breast cancer drug may help thousands more women than previously thought
Pembrolizumab is used to treat triple-negative form of disease but researchers say it could be used more widelyThousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.Pembrolizumab, sold under the brand name Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 19, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Breast cancer UK news Women Health Science NHS Source Type: news

A data duel over U.S. maternal mortality
Experts agree that the U.S. maternal mortality rate is unacceptably high. And year after year of data show that disadvantaged groups, particularly Black and Native American women, die at even higher rates than women in the United States overall during pregnancy and childbirth. But controversy broke out last week over just how bad the situation is, when a paper by academic epidemiologists published in the American Journal of Obstetrics and Gynecology ( AJOG ) provoked unusual pushback from the U.S. Centers for Disease Control and Prevention (CDC). The paper suggested a widely reported tripling in t...
Source: ScienceNOW - March 19, 2024 Category: Science Source Type: news

New Drug Approvals Are the Wrong Metric for Cancer Policy New Drug Approvals Are the Wrong Metric for Cancer Policy
Bishal Gyawali, MD, PhD, has disclosed the following relevant financial relationship: Received consulting fees from: Vivio HealthMedscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 19, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

AstraZeneca to buy fusion for $2 billion
​​The deal gives AstraZeneca a foothold in the radiopharmaceutical drugs market, which has seen increasing investor interest since 2021 when data from Novartis' treatment showed that the drug extended survival for prostate cancer patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2024 Category: Pharmaceuticals Source Type: news

AHN, Baylor Scott & amp; White, and Johns Hopkins researchers confirm effectiveness of new immunotherapy drug combination for gastroesophageal cancer treatment
'Nature Medicine' study, published this week, shows immune checkpoint inhibitor drug therapy, followed by traditional cancer treatment and tumor removal, improved patient survival rates for one of the world's deadliest cancers PITTSBURGH, March 19, 2024 /PRNewswire-PRWeb/ -- Researchers... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news

Can ChatGPT Help Manage Gynecologic Cancers? Can ChatGPT Help Manage Gynecologic Cancers?
ChatGPT accurately answers common questions regarding gynecologic cancers but falls short in providing treatment recommendations, two separate studies found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news